A better future for the NHS: a historical perspective from the frontline

Reynolds, E. H.

doi:10.1177/0141076818790844

Cited by 4 publications

(4 citation statements)

References 12 publications

(12 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many donors do not want to simply plug gaps in government-funded provision and are keen to avoid their donations becoming a substitute for government spending (Breeze, 2010). In a context where accusations of “waste” and “bureaucracy” saturate public and political discourse around funding the NHS (Reynolds, 2018), hospices might struggle to raise funds from donors wary of how efficiently and targeted their money will be spent.…”

Section: Discussionmentioning

confidence: 99%

Funding a “good death”: the financial crisis facing hospices

Scourfield

2023

QAOA

View full text Add to dashboard Cite

Purpose This paper aims to highlight current finding issues relating to the provision of hospice care services which are largely provided by the independent sector and heavily reliant on charitable fund raising. The primary focus is on the UK, but it is an issue of relevance to many other countries around the world. Design/methodology/approach The paper is an opinion piece informed by contemporary reports, official publications and research findings, as well as the author’s own work within the hospice sector. Findings As with many other countries around the world, the bulk of hospice funding in the UK comes from charitable donations of various kinds. However, the impact of COVID-19 highlighted both the fragility of this funding model and the precarious nature of hospice sector finances currently. Practical implications This is an issue of growing importance that affects older people and their families not only in the UK but in all countries with ageing populations. Hospices play an important role in providing end-of-life care and, with demand for services steadily rising due to demographic trends, there are important questions about the sustainability of the current hospice funding model. Social implications Issues of funding require a much higher level of engagement from policymakers if hospice care is going to continue to play a significant part in achieving a good death for people from all sections of society. Originality/value Although hotly debated within the hospice sector and in official reports, this issue has yet to be properly examined within academic circles.

show abstract

Section: Discussionmentioning

confidence: 99%

Funding a “good death”: the financial crisis facing hospices

Scourfield

2023

QAOA

View full text Add to dashboard Cite

show abstract

“…Another predisposing factor to vulnerability to the 2020 Covid pandemic was reduction in the capacity of the NHS initiated by the 1990 NHS and Community Care Act. I have discussed elsewhere 12,13 how the introduction of market forces and fragmentation in the NHS resulted in Service principles being subordinated to or in constant tension with Business principles, such that the NHS has been constantly under pressure with hospitals in particular at near maximum capacity even in summer months. An early sign of this in 1995 was the patient with a severe head injury who had to be helicoptered from Kent to Leeds, where he died, because there were no intensive care beds available in the whole of London or the South East.…”

Section: The Demise Of Local Public Health and The Fragility Of The Nhsmentioning

confidence: 99%

How to avoid harmful national quarantines: primary care led local public health: a historical perspective

Reynolds

2021

J R Soc Med

Self Cite

View full text Add to dashboard Cite

“…Reynolds’s article on a better future for the NHS 1 provides an excellent analysis of the devastating and lasting negative effects of the 1990 NHS Reform Act on the cost and efficiency of the service and the standards of care provided.…”

mentioning

confidence: 99%

Impact of reduced working hours on the NHS

English

2019

J R Soc Med

View full text Add to dashboard Cite

Many thanks indeed for your article by Grant Lewison et al. 1 and for your editorial. 2 The idea that life with advanced cancer can be prolonged at huge cost, not only financial but also in quality of life, has always seemed pointless to me, as a cancer patient myself. Grant Lewison et al. make the point that adverse events are rarely mentioned. This is still a problem even with first-line treatment, in spite of the good work done by the Cochrane Adverse Events Methods Group. The recent Cochrane Collaboration Colloquium ('Patients Included') in Edinburgh did offer a workshop on adverse events, to which I contributed, as a Cochrane 'consumer'. But we still have a long way to go before we have balanced and truthful reporting on drugs. I should like to suggest that no clinical trials should be published in medical journals unless the authors can show that patients have been members of the Trial Steering Committee, and consulted in the drafting of the report, and also that they give a full account of adverse events. 'First do no harm' should apply to researchers as well as clinicians.

show abstract

A better future for the NHS: a historical perspective from the frontline

Cited by 4 publications

References 12 publications

Funding a “good death”: the financial crisis facing hospices

Funding a “good death”: the financial crisis facing hospices

How to avoid harmful national quarantines: primary care led local public health: a historical perspective

Impact of reduced working hours on the NHS

Contact Info

Product

Resources

About